Integra Lifesciences Holdings Corp (IART)
| Market Cap | 1.01B-12.2% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 77.77M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 103,941.106 |
| Open | 12.86 |
| Previous Close | 13.00 |
| Day's Range | 12.82 - 13.21 |
| 52-Week Range | 8.70 - 20.49 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 19.40(+48.66%) |
| Earnings Date | n/a |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About IART
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$IART stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of IART by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 10, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 10, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 9, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Feb 10, 2020 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Feb 10, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Feb 9, 2020 |
Recently reported changes in IART holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by IART's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
IART Estimated quarterly lobbying spending
Source: U.S. Senate LDA
IART Revenue by Segment or Geography
| Segment | Revenue | % of All |
|---|---|---|
| Specialty Surgery | $309.27M | 73.85% |
| Tissue Reconstruction | $109.49M | 26.15% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New IART patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to IART from public contracts
Source: USAspending.gov
IART Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from IART’s recent data — informational, not investment advice
